Moderna | MRNA - Trade Debtors


Moderna reported $71M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.38M 153K Mar/2026
Agios Pharmaceuticals USD 16.13M 5.56M Mar/2026
Alnylam Pharmaceuticals USD 883.96M 106.39M Mar/2026
Amgen USD 9.14B 432M Mar/2026
Arrowhead Research USD 15.68M 203.19M Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
BioMarin Pharmaceutical USD 903.91M 4.3M Mar/2026
Celltrion KRW 2.05T 542.39B Dec/2025
Cspc Pharmaceutical CNY 8.79B 64.64M Dec/2025
Deva Holding AS TRY 3.03B 343.23M Sep/2023
Dianthus Therapeutics USD 52K 4.95M Dec/2025
Divis Laboratories Ltd INR 29.99B 3.71B Mar/2026
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
Gilead Sciences USD 4.74B 172M Mar/2026
GlaxoSmithKline GBP 7.94B 178M Mar/2026
Incyte USD 1.05B 27.09M Mar/2026
Ionis Pharmaceuticals USD 74M 8M Mar/2026
Kangmei Pharma CNY 2.92B 228.09M Mar/2026
Knight Therapeutics CAD 183M 7.46M Dec/2025
Laboratorios Farma EUR 143.38M 16.93M Dec/2023
Malin Corporation EUR 500K 300K Dec/2024
Moderna USD 71M 113M Mar/2026
Organigram Holdings CAD 49.94M 14.92M Dec/2025
Ovoca Bio EUR 39K 408K Jun/2025
Pharma Mar EUR 51.19M 9.4M Mar/2026
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Qiagen NV USD 402.61M 9.05M Dec/2025
Regeneron Pharmaceuticals USD 5.73B 10.1M Mar/2026
Sangamo BioSciences USD 581K 110K Jun/2024
Sarepta Therapeutics USD 547.91M 149.68M Mar/2026
Sartorius EUR 366.6M 74.9M Mar/2026
Sino Biopharmaceutical CNY 8.45B 3.18B Jun/2025
Tilray USD 109.07M 2M Sep/2025
Ultragenyx Pharmaceutical USD 60M 98M Mar/2026
United Therapeutics USD 312M 38.2M Mar/2026
Vertex Pharmaceuticals USD 2B 56.7M Mar/2026
Zealand Pharma A/S 340M 94.1M Dec/2025
Zz Pientze Pharmaceu CNY 1.06B 60.42M Mar/2026